Click here for a PDF version
FOR IMMEDIATE RELEASE
Doctors for America
PO Box 53313
1921 Florida Ave NW
Washington, DC 20009-9997
Doctors for America
Doctors for America’s FDA Task Force Meets with Legislators for a Second Time
Ahead of PDUFA Reauthorization
WASHINGTON, D.C—July 12, 2022. This week Doctors for America’s Food and Drug Administration (FDA) Task Force is meeting with the key policymakers negotiating the Prescription Drug User Fee Act before it expires in September.
The FDA Task Force will be following up on previous meetings with congressional leaders and reaching out to new negotiators and agency officials to discuss the need to ensure clinical trial diversity is included in the final reauthorization package. The FDA Task Force is requesting the final PDUFA package:
- codify making diversity action plans publicly available for independent evaluation; and
- include enforcement measures to ensure representation in clinical trials.
The FDA Task Force is committed to increasing transparency at the FDA and ensuring that patients are at the center of all therapeutic reviews and approvals.
Additionally, the FDA plays a critical role in defending a person’s timely access to reproductive health care services. Clinicians across all specialties look to the FDA for evidence-based guidance on prescription drugs and other medical treatments, including abortion and oral contraception medications. As doctors and other health professionals across the country face increasing uncertainty around whether they can continue to practice in such a way that preserves the privacy and sanctity of the physician-patient relationship, upheld by science, and without threat of penalty, the FDA must provide clarity around the agency’s approval of these critical medications and remove any barriers to accessing them.
For press inquiries for members of the FDA Task Force Doctors for America please contact Claire Onyechi with Continuum Health Group ([email protected]).
About Doctors for America:
Doctors for America mobilizes doctors and medical students to be leaders in putting patients over politics to improve the health of our patients, communities, and nation. We are 27,000 physicians and medical students in all 50 states, representing all areas of specialization. Our impact areas focus on access to affordable care, community health and prevention, and health justice and equity. DFA focuses solely on what is best for our patients, not on the business side of medicine, and does not accept any funding from pharmaceutical or medical device companies; which uniquely positions DFA as the organization that puts patients over politics and patients over profits. Find out more at doctorsforamerica.org and on Twitter @drsforamerica.